Use of IL-15 to increase thymic output and to treat lymphopenia

Details for Australian Patent Application No. 2010282280 (hide)

Owner The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services

Inventors Pavlakis, George N.; Felber, Barbara K.; Valentin, Antonio; Bergamaschi, Cristina

Agent Pizzeys

Pub. Number AU-A-2010282280

PCT Pub. Number WO2011/020047

Priority 61/234,152 14.08.09 US; 61/234,155 14.08.09 US

Filing date 13 August 2010

Wipo publication date 17 February 2011

International Classifications

A61K 38/20 (2006.01) Medicinal preparations containing peptides - Interleukins

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 37/04 (2006.01) Drugs for immunological or allergic disorders

Event Publications

9 February 2012 PCT application entered the National Phase

  PCT publication WO2011/020047 Priority application(s): WO2011/020047

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010282282-Biological markers for monitoring patient response to VEGF antagonists

2010282278-Methods of treating cancer using glucagon-like hormone retargeted endopeptidases